In December 2018, Shanghai Cell Therapy Group Co., Ltd. (the “Company”), a leader in China’s cell therapy medical industry, announced the completion of its C round of financing, raising RMB 925 million (US$134M). The financing was co-led by China Pacific Insurance, Haier Capital, and China Industrial Asset Management Limited, with participation from existing investors Legend Capital, Anting People's Government, and Ningbo Yuanhui. The Company used this round of financing to bring on-board strategic investors that can provide significant business synergies across the various parts of its business. The capital will be used for R&D of innovative cellular technologies and treatments, development of cryopreservation technologies, and the construction of high-end cancer hospitals. CEC Capital served as the exclusive financial adviser for this round of financing.
On November 7, 2018, in Beijing, AI medical imaging leader, HuiyiHuiying, announced that it received investments from Intel Capital and Beijing Kinetic Energy Investment Fund, completing a strategic round of investment. The funds will be used for the comp
Today in Guangzhou, WeRide (formerly known as JingChi.ai)—the leading Level 4 (L4) autonomous vehicle (AV) company in China—announced the completion of its latest round of financing. The strategic lead investor for this round was the Renault-Nissan-Mitsubishi Alliance (RNM Alliance). The follow investors included Hanfor Capital, Atop Capital, Johnson Electric, Mr. Xiaopeng HE (Co-founder of XPENG Motors), idinvest Partners, and OceanIQ. Pre-A round investor Qiming Venture Capital also participated in this most recent round of financing. The Beijing-based investment firm CEC Capital served as a financial adviser to WeRide.
Baidu Video completed its B round of financing with the support from institutional investors including Houze Ruyi, Jadex Capital, and Gfund Management. The lead investor was Baidu and the total investment volume was USD 100 million. CEC Capital served as
The online platform for used cars, Mychebao, announced today that it completed its D round of financing, raising RMB 800 million. Green Harbor Investment was the lead investor and the follow investors included Pacific Alliance Group (PAG), Addor Capital,
Pioneer of the 3D printed pharmaceutical industry, Nanjing Triastek Pharmaceutical Technology Co., Ltd. (also known as “Triastek”), recently raised RMB 100 million, completing its A round of financing. The lead investor was Morningside Venture Capital and the follow investors were Volcanics Ventures and InnoVision Capital. CEC Capital served as the sole financial adviser to CMLabs during this round of financing.
Leading third-party medical testing service provider, Chain Medical Labs (CMLabs), recently announced that it raised hundreds of millions of RMB and the completed its latest B round of financing. The co-lead investors were C-Bridge Capital and Huatai Ruih
AutocloudPro, an auto parts supply chain service company, announced that it had completed Series C financing of RMB 500 million. The round was led by UCAR Capital. This was one of the largest capital raises in the industry.